Public Profile

New England Biolabs Inc.

New England Biolabs Inc. (NEB), headquartered in the United States, is a leading player in the biotechnology industry, specialising in the production of reagents for DNA research. Founded in 1974, NEB has established itself as a pioneer in molecular biology, with significant milestones including the development of innovative enzymes and reagents that have transformed genetic research. With a strong presence in major operational regions worldwide, NEB offers a diverse range of core products, including restriction enzymes, DNA polymerases, and cloning kits, all renowned for their quality and reliability. The company’s commitment to scientific advancement and customer support has solidified its market position, making it a trusted partner for researchers globally. NEB continues to drive innovation, contributing to breakthroughs in genomics and molecular biology.

DitchCarbon Score

How does New England Biolabs Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

New England Biolabs Inc.'s score of 23 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.

49%

New England Biolabs Inc.'s reported carbon emissions

New England Biolabs Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As a leader in the biotechnology industry, the company is expected to engage in climate commitments and initiatives aimed at reducing its environmental impact. However, without specific emissions figures or defined reduction goals, it is challenging to assess their current carbon footprint or progress in sustainability efforts. The absence of data highlights the importance of transparency in corporate climate strategies, particularly in an era where environmental responsibility is increasingly critical for businesses.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. New England Biolabs Inc.'s primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. New England Biolabs Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

New England Biolabs Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Thermo Fisher Scientific

US
Chemicals nec
Updated about 17 hours ago

Illumina

US
Research and development services (73)
Updated 3 days ago

Roche NimbleGen, Inc.

US
Research and development services (73)
Updated about 1 month ago
DitchCarbon Score

Maravai LifeSciences

US
Research and development services (73)
Updated 21 days ago

Danaher Corporation

US
Chemicals nec
Updated 3 days ago

Agilent

US
Other services (93)
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers